Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Genomic profiling of circulating plasma RNA for the analysis of cancer.

Collado M, Garcia V, Garcia JM, Alonso I, Lombardia L, Diaz-Uriarte R, Fernández LA, Zaballos A, Bonilla F, Serrano M.

Clin Chem. 2007 Oct;53(10):1860-3. Epub 2007 Aug 23.

2.

Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.

Uen YH, Lin SR, Wu DC, Su YC, Wu JY, Cheng TL, Chi CW, Wang JY.

Ann Surg. 2007 Dec;246(6):1040-6.

PMID:
18043108
3.

Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer.

Cavalieri D, Dolara P, Mini E, Luceri C, Castagnini C, Toti S, Maciag K, De Filippo C, Nobili S, Morganti M, Napoli C, Tonini G, Baccini M, Biggeri A, Tonelli F, Valanzano R, Orlando C, Gelmini S, Cianchi F, Messerini L, Luzzatto L.

Oncol Res. 2007;16(11):535-48.

PMID:
18306933
4.

Novel blood-based, five-gene biomarker set for the detection of colorectal cancer.

Han M, Liew CT, Zhang HW, Chao S, Zheng R, Yip KT, Song ZY, Li HM, Geng XP, Zhu LX, Lin JJ, Marshall KW, Liew CC.

Clin Cancer Res. 2008 Jan 15;14(2):455-60. doi: 10.1158/1078-0432.CCR-07-1801. Epub 2008 Jan 18.

5.

Gene expression profiling of the bone marrow mononuclear cells from patients with myelodysplastic syndrome.

Qian J, Chen Z, Wang W, Cen J, Xue Y.

Oncol Rep. 2005 Nov;14(5):1189-97.

PMID:
16211284
6.

Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.

Mok SC, Chao J, Skates S, Wong K, Yiu GK, Muto MG, Berkowitz RS, Cramer DW.

J Natl Cancer Inst. 2001 Oct 3;93(19):1458-64.

7.

A homologue of the Drosophila headcase protein is a novel tumor marker for early-stage colorectal cancer.

Chien CC, Chang CC, Yang SH, Chen SH, Huang CJ.

Oncol Rep. 2006 Apr;15(4):919-26.

PMID:
16525680
8.
9.

Sensitive assays for detection of lung cancer. Molecular markers in blood samples.

Fournier MV, Martin KJ, Graner E, Pardee AB.

Methods Mol Med. 2003;75:239-50. No abstract available.

PMID:
12407744
10.

Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma.

Awakura Y, Nakamura E, Takahashi T, Kotani H, Mikami Y, Kadowaki T, Myoumoto A, Akiyama H, Ito N, Kamoto T, Manabe T, Nobumasa H, Tsujimoto G, Ogawa O.

J Cancer Res Clin Oncol. 2008 Dec;134(12):1363-9. doi: 10.1007/s00432-008-0412-4. Epub 2008 May 16.

PMID:
18483744
11.

Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer.

Guller U, Zajac P, Schnider A, Bösch B, Vorburger S, Zuber M, Spagnoli GC, Oertli D, Maurer R, Metzger U, Harder F, Heberer M, Marti WR.

Ann Surg. 2002 Dec;236(6):768-75; discussion 775-6.

12.

A candidate molecular signature associated with tamoxifen failure in primary breast cancer.

Vendrell JA, Robertson KE, Ravel P, Bray SE, Bajard A, Purdie CA, Nguyen C, Hadad SM, Bieche I, Chabaud S, Bachelot T, Thompson AM, Cohen PA.

Breast Cancer Res. 2008;10(5):R88. doi: 10.1186/bcr2158. Epub 2008 Oct 17.

13.

Effectiveness of gene expression profiling for response prediction of rectal cancer to preoperative radiotherapy.

Ojima E, Inoue Y, Miki C, Mori M, Kusunoki M.

J Gastroenterol. 2007 Sep;42(9):730-6. Epub 2007 Sep 25.

PMID:
17876542
15.

Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification.

DePrimo SE, Wong LM, Khatry DB, Nicholas SL, Manning WC, Smolich BD, O'Farrell AM, Cherrington JM.

BMC Cancer. 2003 Feb 7;3:3. Epub 2003 Feb 7.

16.

[Screening of differentially expressed genes in colorectal cancer using human whole genomic oligonucleotide microarrays].

Xu HM, Wang Q, Bai XJ, Zhong DR, Cao XT, Zhang JP, Ding YQ, Yao KT.

Di Yi Jun Yi Da Xue Xue Bao. 2005 Sep;25(9):1109-13. Chinese.

17.

Novel blood biomarkers of human urinary bladder cancer.

Osman I, Bajorin DF, Sun TT, Zhong H, Douglas D, Scattergood J, Zheng R, Han M, Marshall KW, Liew CC.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3374-80.

18.

Expression profiling of fecal colonocytes for RNA-based screening of colorectal cancer.

Yajima S, Ishii M, Matsushita H, Aoyagi K, Yoshimatsu K, Kaneko H, Yamamoto N, Teramoto T, Yoshida T, Matsumura Y, Sasaki H.

Int J Oncol. 2007 Nov;31(5):1029-37.

PMID:
17912428
19.

Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.

Chakrabarti R, Robles LD, Gibson J, Muroski M.

Cancer Genet Cytogenet. 2002 Dec;139(2):115-25.

PMID:
12550771
20.

A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.

Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.

Gastroenterology. 2009 Jul;137(1):165-75. doi: 10.1053/j.gastro.2009.03.041. Epub 2009 Mar 26.

PMID:
19328798
Items per page

Supplemental Content

Write to the Help Desk